Lapatinib and Gemcitabine for Metastatic Pancreatic Cancer-Reference-Cited by-同舟云学术

Lapatinib and Gemcitabine for Metastatic Pancreatic Cancer

Published:2011-02 Issue:1 Volume:34 Page:50-52
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Safran Howard,Miner Thomas,Bahary Nathan,Whiting Sam,Lopez Charles D.,Sun Weijing,Charpentier Kevin,Shipley Joshua,Anderson Elliot,McNulty Brendan,Schumacher Andrew,Clark Alessandra,Vakharia Jamsheed,Kennedy Teresa,Sio Terence

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference12 articles.

1. Antitumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways.;Xia;Oncogene,2002

2. Overexpression of the HER-2/neu oncogene in pancreatic adenocarcinoma.;Safran;Am J Clin Oncol,2001

3. Developing inhibitors of the epidermal growth factor receptor for cancer treatment.;Grunwald;J Natl Cancer Inst,2003

4. Untangling the ErbB signaling network.;Yarden;Nat Rev Mol Cell Biol,2001

5. ErbB2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling.;Graus-Porta;EMBO,1997

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of the RAF/MEK/ERK Signaling Cascade in Pancreatic Cancer: Recent Advances and Future Perspectives;International Journal of Molecular Sciences;2024-01-28

2. Photodynamic Stromal Depletion in Pancreatic Ductal Adenocarcinoma;Cancers;2023-08-16

3. Telemedicine in Neuro-Oncology—An Evaluation of Remote Consultations during the COVID-19 Pandemic;Cancers;2023-08-11

4. HROP68: A rare case of medullary pancreatic cancer—characterization and chemosensitivity of the first patient-derived cell line;Frontiers in Oncology;2023-01-20

5. The role of molecular testing in pancreatic cancer;Therapeutic Advances in Gastroenterology;2023-01